Oncology advances in screening and treatment

Explore genetic cancer screening options in veterinary oncology, including Oncok9. Learn about Laverdia, a new drug in the treatment of lymphoma, and the basics of cancer vaccines.

This session originally was presented at AVMA Convention 2022. 

Participants can expect to learn about:

  • Mechanism of action and adverse event profile of Laverdia
  • Oncok9, a relatively new cancer screening test for dogs
  • Basics of autologous vaccines and which companies offer them as a treatment option

Dr. Craig Clifford earned his DVM from Mississippi State University and completed his oncology residency at the University of Pennsylvania. He became a diplomate of the American College of Veterinary Internal Medicine (Oncology) in 2003. Dr. Clifford has served as director of clinical studies at Blue Pearl Malvern in Pennsylvania. He also is active in clinical research within a referral setting and serves as an advisory board member for both industry and non-profit foundations. He has authored or co-authored over 70 papers and book chapters and is a frequent lecturer at veterinary meetings nationally and internationally. Among other positions, he has served as a member of VCA Animal Hospitals’ Pet Cancer Care Alliance Committee and the Veterinary Cancer Society’s executive board.